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Sir,
Several studies have reported that high-risk human papilloma-
viruses (HPVs) are present in more than 50% of human breast
cancers (Yu et al, 2000; Liu et al, 2001; Damin et al, 2004; de
Villiers et al, 2005; Kan et al, 2005; Lawson et al, 2006a,b; Yasmeen
et al, 2007a,b). Furthermore, high-risk HPVs of the same type were
found in both cervical and breast cancer of the same patients
(Hennig et al, 1999; Widschwendter et al, 2004). This finding has
led to the hypothesis that HPVs could be transmitted to the breast
through sexual activities (Kan et al, 2005; Lawson et al, 2006a,b).
Consequently, it is possible that the incidence of HPV-positive
breast cancer in young women is related to high-risk HPV genital
infections, which are much more common in young women who
have multiple sexual partners (IARC, 1995).
There are three studies concerning the age of women in relation
to the incidence of high-risk HPV-positive breast cancer. While
there were no differences in the average age of women with either
HPV-positive or -negative breast cancer in Brazilian women
(Damin et al, 2004). In contrast, two recent studies reported that
the average age of HPV-positive breast cancer in Greek and
Australian women are 38 and 55.6 years in comparison with HPV-
negative breast cancer, which are 53 and 63.8 years (P¼0.001 and
0.049), respectively, (Kroupis et al, 2006; Lawson et al, 2006a,b).
We recently reported that E6/E7 of HPV type 16 is present in the
majority of invasive and metastatic breast cancer in comparison to
normal mammary tissues in young Canadian women (Yasmeen
et al, 2007a,b). Moreover, we were able to demonstrate that the
presence of E6/E7 of high-risk HPVs is correlated with invasive
breast cancer in young Syrian women (Akil et al, in preparation);
in this study, we documented the ages of Canadian and Syrian
women in relation to their HPVs status. We found a statistically
significant difference between the average age of women with high-
risk HPV-positive breast cancers, which was 46.5 years in
comparison with HPV-negative breast cancers of 57.5 years
(P¼0.05). Our data suggest that high-risk HPV-positive breast
cancers are more frequent in younger women who are probably
sexually more active than older women who have less sexual
activity; thus, we firmly believe that high-risk HPV infections
can be transmitted by sexual activity and could play an important
role in the progression of human breast cancer. However,
future epidemiological studies are necessary to confirm these
findings.
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